121 - 125 out of 125Page size: 10
  1. 2024

  2. Characterizing a lethal CAG-ACE2 transgenic mouse model for SARS-CoV-2 infection using Cas9-enhanced nanopore sequencing

    Smirnov, A., Nurislamov, A., Koncevaya, G., Serova, I., Kabirova, E., Chuyko, E., Maltceva, E., Savoskin, M., Zadorozhny, D., Svyatchenko, V. A., Protopopova, E. V., Taranov, O. S., Legostaev, S. S., Loktev, V. B., Serov, O. & Battulin, N., Oct 2024, In: Transgenic Research. 33, 5, p. 453-466 14 p.

    Research output: Contribution to journal › Article › peer-review

  3. Platelet activation near point-like source of agonist: Experimental insights and computational model

    Starodubtseva, E. S., Karogodina, T. Y. & Moskalensky, A. E., 1 Oct 2024, In: PLoS ONE. 19, 10, 13 p., e0308679.

    Research output: Contribution to journal › Article › peer-review

  4. Adrenochrome formation during photochemical decomposition of “caged” epinephrine derivatives

    Starodubtseva, E. S., Karogodina, T. Y., Panfilov, M. A., Sheven, D. G., Selyutina, O. Y., Vorob’ev, A. Y. & Moskalensky, A. E., Dec 2024, In: Photochemical and Photobiological Sciences. 23, 12, p. 2265–2268 4 p.

    Research output: Contribution to journal › Article › peer-review

  5. Методика изготовления полимерных биосовместимых материалов с функцией выделения оксида азота, управляемого светом

    Москаленский, А. Е., Панфилов, М. А. & Воробьев, А. Ю., 10 Dec 2024, Редакционно-издательский центр НГУ, Patent No. 116, 10 Dec 2024, Priority date 10 Dec 2024

    Research output: Patent › Know-how registration

  6. 2025

  7. Reducing the Formation of Toxic Byproducts During the Photochemical Release of Epinephrine

    Panfilov, M. A., Starodubtseva, E. S., Karogodina, T. Y., Vorob’ev, A. Y. & Moskalensky, A. E., 8 Jan 2025, In: Journal of Xenobiotics. 15, 1, 8.

    Research output: Contribution to journal › Article › peer-review

Previous 1...9 10 11 12 13 Next

ID: 3087822